Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
1997, Journal of Pediatric Surgery
…
2 pages
1 file
Journal of Pediatric Surgery, 2012
This is a case report of the first patient with Alagille syndrome (AGS) to undergo a partial internal biliary diversion (PIBD) for the treatment of symptoms refractory to medical therapy. Alagille syndrome is a hereditary disease resulting in chronic cholestasis and hypercholesterolemia that can lead to severe and intractable pruritus and disfiguring and debilitating xanthomas. PIBD has proven to be an effective treatment option for other causes of cholestatic liver disease. This report reviews the immediate and 2-year follow-up of a patient after this surgical procedure. The results suggest that PIBD has potential to provide relief of intractable symptoms and improve the quality of life in patients with AGS while avoiding an external stoma. It does not, however, appear to prevent the progression of liver disease. Long-term follow-up is still needed.
Acta Medica Portuguesa, 2010
The Journal of Pediatrics, 1995
Objective: To determine the outcome, in index patients followed at an American Center, of syndromic paucity of interlobular bile ducts (sPILBD; Alagille syndrome), with onset of cholestasis in infancy.
Zenodo (CERN European Organization for Nuclear Research), 2020
Background: Biliary atresia (BA) is a serious pediatric condition that tends to progress to cirrhosis, liver failure, and death within a short time. It is the result of a continuous inflammatory, sclerosing, destructive process in the biliary tract and the most common indication for liver transplantation. Material and methods: The study included 46 patients up to 1 year of age hospitalized with cholestasis syndrome in IMSP IM and C, during the years 2014-2019. The basic methods in the diagnosis of BA were the biochemical examination, FGDS, USG doppler dupplex color of the biliary system before and after the meal intake, MRI with cholangiography, dynamic hepatobiliary scintigraphy. Results: Following the analysis of clinical and paraclinical results, surgical pathology was excluded in 25 patients, the diagnosis of BA was established in 11 cases. 6 patients with BA underwent Kasai surgical intervention , a primary liver transplant was performed in 3 cases, and 2 patients died before the surgery. Conclusions: Portoenteroanastamosis (Kasai operation) performed as early as possible (up to 60 days postnatal) considerably increases life expectancy. The embryonic form of BA is a severe condition that is indicated for the initial liver transplant.The prognosis of untreated biliary atresia is unfavorable, leading to the death of most children in the first 2 years of life due to liver failure. In decopensated late-diagnosed cases, liver transplantation remains the only treatment option.
Romanian journal of gastroenterology, 2005
BACKGROUND The use of the Roux-en-Y procedure is limited in paediatric surgery practice, and is performed mainly in congenital hepatobiliary disorders either as an initial or permanent treatment. In this 18-year retrospective study, we present our experience of the Roux-en-Y procedure in childhood cases of biliary atresia (BA) and congenital choledochal cyst (CCC). METHODS Twenty-eight children (18 females and 10 males; age 25 days-12 years) with hepatobiliary disorders were treated in our clinics between 1986-2004. Twenty patients suffered from BA (11 females, 9 males) and eight from CCC (seven females, one male). The surgical approach in the patients with BA (mean age 2.1 months) was Roux-en-Y hepatic portoenterostomy (Kasai procedure) and in the patients with CCC (mean age 7.2 years) was cyst excision with Roux-en-Y hepaticojejunostomy. The mean follow up period was 9.3 years. RESULTS The children with BA developed the follow postoperative complications: 12 cholangitis, 6 portal ...
Pediatric Transplantation, 2010
AGS, syndromatic paucity of intrahepatic bile ducts, is an autosomal dominant, multisystem disorder that primarily affects the liver, heart, eyes, face, and skeleton (1, 2). It occurs in approximately one in 70 000 live births based on the presence of neonatal cholestasis (3). However, this may be an underestimate as molecular testing has demonstrated that many individuals with a disease-causing mutation do not have neonatal liver disease (4). The first reports underestimated the clinical significance of liver disease in children with AGS. It was considered a ''benign'' syndrome of intrahepatic cholestasis, liver complications were considered responsible for death in 5% of patients and considered to be ''rare'' indications for LT (5). Over the past 20 yr, there have been reports suggesting that the severity of liver involvement may be higher than originally estimated with liver failure and/or hepatocellular carcinoma occurring in children as young as two to four yr (6). Treatment of AGS depends on the distribution and the severity of the clinical symptoms and the outcome is related to the extent of the hepatic and extrahepatic disease (7). The majority of AGS can be treated conservatively with optimization of nutrition, supplementation of fat soluble vitamins, or drugs to relieve the severe pruritus. Biliary diversion and ileal exclusion can be helpful in some patients for refractory pruritus and xanthomas (8-12). It is difficult to establish clear criteria for LT in children with AGS because of the wide variety of clinical symptoms and the multisystem involvement. Historically, LT has been performed in patients with AGS for refractory pruritus, xanthomas, and complications of end stage cholestatic liver disease (7, 13). Only small, singlecenter studies reported the outcomes of LT of patients with AGS (13-15).
Journal of Medical Case Reports, 2016
Background: Alagille syndrome, a rare genetic disorder with autosomal dominant transmission, manifests with five major features: paucity of interlobular bile ducts, characteristic facies, posterior embryotoxon, vertebral defects, and peripheral pulmonary stenosis. Globally, only 500 cases have so far been reported, with only five cases reported in the Indian subcontinent. Rarely, Alagille syndrome also presents with skin manifestations and early-onset chronic liver disease, which was found in our case. We believe that we report what could be the first case of Alagille syndrome presenting with café au lait spots, as no such published case report could be found in the literature. Case presentation: We report an unusual case of childhood cholestatic jaundice with neonatal onset of jaundice. A 10-year-old boy from the Indian subcontinent presented with obstructive jaundice from early infancy. He also had recurrent fractures of his upper limb bones, intermittent bleeding from his nose, productive cough, decreased night vision, hyperpigmented spots over his skin, and progressive enlargement of his abdomen. Histological examination of a liver biopsy specimen revealed a paucity of bile ducts and changes suggestive of chronic liver disease. Our patient was diagnosed with Alagille syndrome and managed conservatively but died 1 year after the final diagnosis. Conclusions: This particular syndromic form of paucity of bile duct disorder has been rarely reported in the Indian literature so far. Our case is notable because the child had café au lait spots and very early onset of chronic liver disease, which is quite rare in Alagille syndrome. We believe this to be the first case report on Alagille syndrome manifesting with café au lait syndrome and such early onset of chronic liver disease.
European Society of Anesthesia Newsletter, 2019
Despite the many advances in technology, there still are high levels of preventable harm in anaesthesia care leading some to characterize our profession’s approach to care as “primitive, fragmented, and cavalier”. Surgery is more aggressive than before, less with the knife, more with scopic interventions, yet our patients are older, overweight, have multiple co-morbidities, and are more fragile. More than 18 years after the Institute of Medicine report, the evidence suggests that we are still harming many patients, yet the types of errors are changing. Healthcare costs continue to rise at alarming rates while quality of care is highly variable, forcing hospitals to demand more safety, efficiency, and harder work from their clinical staff. A human factors approach is needed to engage clinicians, architects, and engineers to address perioperative flow, comprehensive data availability, safety, teamwork, and data overload (including alarm fatigue) and its implications for planning the physical built environment. We can learn from other industries about more effective integration of robotics, better self and patient monitoring, smarter automation, better team communication, andresilience to provide more patient centred, safe and reliable care.
H-Environment, 2024
Byzantinische Zeitschrift, 2011
Digital government, 2024
Religión y Política. Perspectivas América Latina - Europa, 2008
Planlama dergisi, 2021
Electric Power Distribution Engineering, 2015
Social Science Computer Review, 2004
Preventive nutrition and food science, 2012
California Agriculture, 1983
Journal of Food Process Engineering, 2014
Journal of Cleaner Production, 2015
Wiener Medizinische Wochenschrift, 2009